You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
2 June 2026 - Biopharmaceutical company UCB (EBR:UCB) announced on Monday the launch of the inaugural UCB Hidradenitis Suppurativa Scholarship Program.This program is designed to support adults age 18 and older living with hidradenitis suppurativa (H...
2 June 2026 - US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Monday that it has received marketing authorisation from the European Commission for IMDYLLTRA (tarlatamab) as a monotherapy to treat adults with extensive-stage small cell l...
2 June 2026 - The Heart Rhythm Society (HRS) announced on Monday that it has formed a collaboration with Milestone Pharmaceuticals, an emerging commercial-stage biopharmaceutical company advancing innovative cardiovascular medicines for certain heart...
1 June 2026 - Biotechnology company Anixa Biosciences Inc (NASDAQ: ANIX) reported on Monday that it has received a Notice of Allowance from the Canadian Intellectual Property Office for a patent covering key aspects of its ovarian cancer vaccine tech...
1 June 2026 - Clinical development partner hVIVO plc (AIM: HVO) announced on Monday that it has signed a consultancy agreement with Decoy Therapeutics to support the development of its respiratory antiviral portfolio, positioning the programmes for p...
1 June 2026 - Clinical-stage biotechnology companies Rallybio Corporation (Nasdaq:RLYB) and Avenzo Therapeutics Inc announced on Monday that they have entered into a definitive merger agreement under which Rallybio will acquire Avenzo, with the combi...